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Abstract
Background: There is a paucity of data on the distribution of disease severity. In this study, we estimated disease
severity distributions in South Korea using two EQ-5D-3L population surveys.
Methods: A total of 110 health states for 35 diseases with 2–5 severity levels (e.g., mild, moderate, severe) were
included in this study. A general population of 360 participants from the areas surrounding Seoul and Gyunggi
evaluated these health states using EQ-5D-3L via face-to-face interviews and a paper questionnaire. The EQ-5D
indices were used to measure the severity levels of health states and used as the cutoff points for the disease
severity distributions. Finally, these cutoff points were applied to disease prevalence data with EQ-5D-3L, which
were obtained from the Korean National Health and Nutrition Examination Surveys (KNHNES) and Korean
Community Health Survey, in order to estimate the disease severity distributions.
Results: The severity distributions of 8 diseases were estimated, including asthma, angina, stroke, chronic
obstructive pulmonary disease, major depressive disorder, musculoskeletal problems in the legs, anemia, and
allergic rhinitis and conjunctivitis. For example, the EQ-5D indices for chronic obstructive pulmonary disease severity
were 0.929, 0.742, and 0.620, and the cut-off points were 0.835 (between mild and moderate) and 0.681 (between
moderate and severe). Using these cutoff points, the distributions of chronic obstructive pulmonary disease severity
were 66.5 % (mild), 23.3 % (moderate), and 10.1 % (severe) according to KNHNES.
Conclusions: The estimated severity distributions in this study can be used as a valid calculation of the disease
burden in the general population.
Keywords: Disease severity, Prevalence, EQ-5D
Background
The disability-adjusted life year (DALY) is a summary
measure of overall disease burden and is expressed in
terms of the number of years lost due to poor health,
disability, or early death [1]. DALY has 2 components:
years of life lost (YLLs) and years lived with disability
(YLDs). This measure was first developed in 1990 as an
approach for comparing the overall health and life ex-
pectancies of different countries [2]. Recently, the Global
Burden of Disease (GBD) study group adopted a
prevalence-based approach rather than an incidence-
based approach [3]. Using both approaches, the YLL
component is calculated using the same principle, which
takes advantage of the number of deaths and standard
life expectancy at age of death in years. However, when
determining the YLD component, there are some differ-
ences between the 2 approaches in terms of disease
duration, disability weight, and comorbidity [4]. Using
the prevalence-based approach, disease duration is not
directly considered and the disability weights are applied
to the disease sequelae rather than the disease itself. In
addition, it is easier to consider comorbidity using the
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Notably, the prevalence-based approach uses big
changes related to disability weight. In fact, after the de-
velopment of DALYs, there have been some debates on
the measurement of health loss, the use of person trade-
offs, disability weights of whose perspectives, and the
universality of disability weights [5]. In their 2010 study,
the GBD group conducted international surveys on the
general public using paired comparisons to estimate dis-
ability weights [6]. These changes make it easier to cal-
culate DALYs, but this approach requires more data that
were not needed when using the incidence-based ap-
proach, such as data about severity distribution [7].
Using the prevalence-based approach, the GBD group
attempted to consider sequelae severity and briefly de-
scribed the health state and sequelae severity [6]. In
order to apply data on severity distributions and calcu-
late DALYs, the GBD group asked a convenient sample
of participants to evaluate SF-12v2 [8] for a hypothetical
person, who was depicted as living with a certain health
state from among 60 possible health states [9]. The GBD
group then used population survey data from the United
States and Australia to estimate marginal severity
distributions.
They adapted this method because data on severity
distributions are often scarce. However, applying the
data on severity distributions from one country to an-
other would impose limitations due to differences in
race, economic factors, and healthcare system accessibil-
ity [10, 11]. In South Korea, two population surveys are
available, the Korean National Health and Nutrition
Examination Surveys (KNHNES) and Korean Commu-
nity Health Survey (KCHS), which have prevalence data
and health-related quality of life (HRQoL) data using
EQ-5D-3L [12]. Therefore, disease severity distributions
could be determined from the KNHNES and KCHS
modifying the method used in the GBD study. In our
current study, we estimated disease severity distributions
in the Korean general population using two EQ-5D-3L




A general population of 360 adults (≥19 years) from the
areas surrounding Seoul and Gyunggi participated in this
study. The study participants were recruited and strati-
fied according to age, sex, and education using data from
the 2010 Census of Korea. The sample size was deter-
mined by allocating 30 participants to each health state
group (12 health state groups).
Ethical considerations
This survey was conducted by a commercial survey
company, who used face-to-face interviews and paper
questionnaires after obtaining informed consent. This
study was approved by the institutional review board of
Asan Medical Center (S2014-1677-0002).
Health state valuation survey procedure and health states
First, sociodemographic characteristics were determined,
such as sex, age group, region, and education level. Sec-
ond, each study participant described their own health
states using EQ-5D-3L to adapt to the instrument.
Lastly, the study participants were asked to complete
EQ-5D-3L for 9 or 10 hypothetical people, as described
by the lay descriptions of health states in the order of
good health states.
In total, 110 health states of 35 diseases with 2–5
severity levels (e.g. mild, moderate, and severe) were
included in this study. Those health states mainly
originated from 220 health states, which were de-
scribed in the 2010 GBD study [6]. Each health state
was depicted in terms of the lay descriptions, which
described the status of each health state in terms of
several health aspects. Because the lay descriptions
were originally developed in English, MO first trans-
lated these descriptions, which were rechecked by
MWJ. In addition, 4 diseases—allergic rhinitis and
conjunctivitis, annoyance, sleep disturbance, and cog-
nitive impairment in children—were included in this
study, because of local national burden of disease
study for environmental diseases. The health states of
additional 4 diseases were drafted by 2 authors (MO
and MWJ) after referencing the existing lay descrip-
tions reported by a previous study [6]. These 110
health states were divided into 12 groups, which were
composed of 9–10 health states. Thirty participants
were allocated to each health state group, therefore,
each health state had 30 EQ-5D-3L responses. Excep-
tionally, the 3 health states related to anemia included
2 groups, so each health state of anemia had 60 EQ-
5D-3L responses. We considered that at least 30 EQ-
5D-3L responses using mean as a representative value
would make parametric statistical tests possible.
Table 2 lists the diseases and severity levels.
Analysis
Descriptive analyses of the basic characteristics of the
study participants were first conducted. Then, the se-
verity distributions were estimated using survey data
obtained by this study and prior population survey
data. Figure 1 shows the approach for estimating the
severity distributions of the health states in this study.
The EQ-5D-3L responses from each health state were
transformed to the EQ-5D-3L index using the Korean
EQ-5D-3L value set [13]. We used EQ-5D-3L rather
than SF-12v2 because the KNHNES and KCHS
adapted EQ-5D-3L to measure HRQoL. KNHNES and
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KCHS report different self-reported prevalence data
by year. The cutoff points for the severity distribu-
tions of each disease were determined according to
the averages of the mean values of the EQ-5D-3L
index for the severity levels of the health states. Fi-
nally, these cutoff points were applied to the disease
prevalence data from KNHNES and KCHS in order
to estimate the disease severity distributions. We used
pooled data from KNHNES (obtained between 2005
and 2012) and KCHS (2008–2012), respectively. All
statistical analyses were conducted using SPSS 21.0
software.
Results
The basic characteristics and self-perceived HRQoL
values of the study participants are listed in Table 1. In
total, 50.6 % of the study participants (182 participants)
were female. Participants in their 40s and residents of
Gyunggi were the largest groups. These characteristics
are similar to those reported for the general public in
Seoul, Inchon, and Gyunggi. The mean EQ-5D index
was 0.971 (standard deviation 0.08; median 1.000).
Table 2 presents the means and standard deviations
of the EQ-5D-3L indices according to the severity
levels of 35 diseases. The raw survey data related EQ-
Fig. 1 Approach used in this study to estimate disease severity distribution
Table 1 Basic characteristics of the study participants
Number Percent
Gender Female 182 50.6
Male 178 49.4





Region Seoul 148 41.1
Incheon 41 11.4
Gyunggi 171 47.5





Self perceived health related quality of life (EQ-5D-3L index) 0.971 (0.08)
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Table 2 Characteristics of the EQ-5D-3L index for diseases by severity level
No Disease Severity level Response
number
Mean SD Cut-off
1 Infectious disease Acute episode, mild 30 0.934 0.068 -
Acute episode, moderate 30 0.802 0.099 0.868
Acute episode, severe 30 0.521 0.236 0.661
2 Diarrhoea Mild 30 0.753 0.168 -
Moderate 30 0.644 0.203 0.699
Severe 30 0.353 0.287 0.498
3 Angina pectoris Mild 30 0.687 0.372 -
Moderate 30 0.663 0.318 0.675
Severe 30 0.506 0.324 0.585
4 Heart failure Mild 30 0.793 0.184 -
Moderate 30 0.688 0.236 0.741
Severe 30 0.478 0.206 0.583
5 Stroke Long-term consequences, mild 30 0.567 0.276 -
Long-term consequences, moderate 30 0.491 0.287 0.529
Long-term consequences, moderate plus cognition problems 30 0.311 0.348 0.401
Long-term consequences, severe 30 −0.035 0.197 0.138
Long-term consequences, severe plus cognition problems 30 −0.092 0.139 −0.064
6 Asthma Controlled 30 0.956 0.072 -
Partially controlled 30 0.849 0.139 0.902
Uncontrolled 30 0.717 0.228 0.783
7 COPD & other respiratory problems Mild 30 0.929 0.108 -
Moderate 30 0.742 0.191 0.835
Severe 30 0.620 0.245 0.681
8 Dementia Mild 30 0.840 0.175 -
Moderate 30 0.648 0.223 0.744
Severe 30 0.181 0.407 0.415
9 Multiple sclerosis Mild 30 0.785 0.153 -
Moderate 30 0.648 0.197 0.717
Severe 30 0.556 0.266 0.602
10 Epilepsy Treated, seizure free 30 0.686 0.207 -
Treated, with recent seizure 30 0.545 0.225 0.615
Untreated 30 0.542 0.258 0.544
Severe 30 0.345 0.303 0.443
11 Parkinson’s disease Mild 30 0.849 0.127 -
Moderate 30 0.686 0.191 0.767
Severe 30 0.344 0.333 0.515
12 Alcohol use disorder Mild 30 0.755 0.220 -
Moderate 30 0.730 0.207 0.743
Severe 30 0.494 0.247 0.612
13 Fetal alcohol syndrome Mild 30 0.850 0.136 -
Moderate 30 0.731 0.135 0.79
Severe 30 0.426 0.256 0.579
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Table 2 Characteristics of the EQ-5D-3L index for diseases by severity level (Continued)
14 Anxiety disorder Mild 30 0.927 0.080 -
Moderate 30 0.835 0.117 0.881
Severe 30 0.612 0.282 0.723
15 Major depressive disorder Mild 30 0.813 0.157 -
Moderate 30 0.436 0.345 0.624
Severe 30 0.159 0.366 0.298
16 Intellectual disability Mild 30 0.662 0.311 -
Moderate 30 0.685 0.215 0.673
Severe 30 0.444 0.291 0.564
Profound 30 0.383 0.286 0.414
17 Hearing loss Mild 30 0.877 0.167 -
Moderate 30 0.720 0.204 0.799
Severe 30 0.710 0.170 0.715
Profound 30 0.528 0.206 0.619
Complete 30 0.366 0.312 0.447
18 Hearing loss with ringing Mild 30 0.675 0.319 -
Moderate 30 0.635 0.248 0.655
Severe 30 0.528 0.317 0.581
Profound 30 0.454 0.282 0.491
Complete 30 0.368 0.287 0.411
19 Distant vision Mild impairment 30 0.949 0.109 -
Moderate impairment 30 0.719 0.199 0.834
Severe impairment 30 0.429 0.333 0.574
Blindness 30 0.221 0.296 0.325
20 Low back pain Acute without leg pain 30 0.446 0.363 -
Acute with leg pain 30 0.308 0.357 0.377
Chronic without leg pain 30 0.342 0.351 0.325
Chronic with leg pain 30 0.188 0.272 0.265
21 Neck pain Acute mild 30 0.694 0.169 -
Acute severe 30 0.504 0.28 0.599
Chronic mild 30 0.544 0.209 0.524
Chronic severe 30 0.361 0.323 0.453
22 Musculoskeletal problems: leg Mild 30 0.786 0.068 -
Moderate 30 0.726 0.057 0.756
Severe 30 0.539 0.185 0.633
23 Musculoskeletal problems: arms Mild 30 0.438 0.354 -
Moderate 30 0.317 0.320 0.377
24 Musculoskeletal problems:
generalised
Moderate 30 0.360 0.314 -
Severe 30 0.111 0.307 0.235
25 Abdominopelvic problem Mild 30 0.882 0.063 -
Moderate 30 0.699 0.156 0.791
Severe 30 0.238 0.250 0.469
26 Disfigurement Level 1 30 0.866 0.093 -
Level 2 30 0.736 0.186 0.801
Level 3 30 0.662 0.26 0.699
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5D-3L indices are available in the Additional file 1.
The cutoff points were also calculated using the aver-
ages of the mean values of the EQ-5D-3L index for
the severity levels of the health states. In the case of
asthma, the EQ-5D-3L indices according to severity
level were 0.956 (controlled), 0.849 (partially con-
trolled), and 0.717 (uncontrolled). The cutoff points
were 0.902 (between controlled and partially con-
trolled) and 0.783 (between partially controlled and
uncontrolled).
Some health states had negative mean values for
their EQ-5D-3L indices. For example, the mean values
of the EQ-5D-3L indices for “stroke: long-term conse-
quences, severe” and “stroke: long-term consequences,
severe plus cognition problems” were −0.035 and
−0.092, respectively. Consequently, the cutoff point
between “stroke: long-term consequences, severe” and
“stroke: long-term consequences, severe plus cogni-
tion problems” was also negative at −0.064. However,
the other cutoff values were all positive.
The severity distributions for 8 diseases were esti-
mated using these cutoff values: asthma, angina,
stroke, chronic obstructive pulmonary disease
(COPD), major depressive disorder, musculoskeletal
problem in legs, anemia, and allergic rhinitis and con-
junctivitis (Table 3). The severity distributions of the
other diseases, such as dementia and epilepsy, could
not be estimated because the participants who had
these diseases (such as dementia or epilepsy) did not
have an EQ −5D profile in both KNHNES and KCHS.
Overall, the proportion of participants with mild dis-
ease severity was larger than the proportion of mod-
erate or severe disease severity for each disease. For
example, the proportions of “stroke: long-term conse-
quences, mild” were 86.4 % (KNHNES) and 81.0 %
(KCHS), whereas those of “stroke: long-term conse-
quences, severe” were only 1.9 % (KNHNES) and
5.0 % (KCHS). In the case of major depressive dis-
order, the distributions of severity were 88.8 % (mild),
9.8 % (moderate), and 1.5 % (severe) according to
KNHNES. However, the proportions of severe cases
with asthma, COPD, and musculoskeletal problems in
the legs were >10 %. In particular, the severity distri-
butions for asthma were 52.4 % (controlled), 14.4 %
(partially controlled), and 33.2 % (uncontrolled) ac-
cording to KCHS.
Table 2 Characteristics of the EQ-5D-3L index for diseases by severity level (Continued)
27 Disfigurement: with itch or pain Level 1 30 0.721 0.183 -
Level 2 30 0.551 0.255 0.636
Level 3 30 0.145 0.272 0.348
28 Motor impairment Mild 30 0.817 0.151 -
Moderate 30 0.648 0.151 0.733
Severe 30 0.129 0.330 0.389
29 Motor plus cognitive impairment Mild 30 0.622 0.236 -
Moderate 30 0.394 0.335 0.508
Severe 30 −0.004 0.237 0.195
30 Traumatic brain injury long-term consequences, minor with or without treatment 30 0.513 0.254 -
long-term consequences, moderate with or without
treatment
30 0.161 0.279 0.337
long-term consequences, severe with or without treatment 30 −0.001 0.319 0.080
31 Anemia Mild 60 0.802 0.287 -
Moderate 60 0.596 0.313 0.699
Severe 60 0.416 0.335 0.506
32 Allergic rhinitis and conjunctivitis Mild 30 0.694 0.288 -
Moderate 30 0.645 0.269 0.670
33 Annoyance Mild 30 0.805 0.264 -
Severe 30 0.676 0.305 0.740
34 Sleep disturbance Mild 30 0.894 0.111 -
Severe 30 0.807 0.208 0.851
35 Cognitive impairment in children Mild 30 0.838 0.258 -
Severe 30 0.816 0.181 0.827
SD standard deviation, COPD chronic obstructive pulmonary disease
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Discussion
We have estimated the severity distributions of 8 dis-
eases (asthma, angina, stroke, COPD, major depres-
sive disorder, musculoskeletal problem in legs,
anemia, and allergic rhinitis and conjunctivitis) using
EQ-5D-3L. We performed face-to-face interviews, in
which the survey participants completed the EQ-5D-
3L for a hypothetical person as depicted by the lay
descriptions explaining the health states of diseases.
The EQ-5D-3L index was calculated for each health
state using survey data obtained by this study, and
the cutoff points for the severity distributions of each
disease were determined according to the averages of
the means of the EQ-5D-3L index for the severity
levels of the health states. These cutoff points were
applied to disease prevalence data obtained from
population surveys performed at the national level
(KNHNES and KCHS), and the severity distributions
for each disease were estimated.
In terms of methodology, this study approach is simi-
lar to the indirect elicitation methods used to generate
HRQoL weights [14]. The generic preference-based in-
struments such as EQ-5D and Health Utilities Index are
generally used to evaluate status of health states devel-
oped to cover key aspects including physical and mental
health in the indirect elicitation method. Although the
measured aspects of health will differ depending on the
instrument, it is easy to perform similar studies and
comparability can be assured across diseases and coun-
tries. If there are prevalence data about HRQoL in other
Table 3 Estimated disease severity distributions
No Disease Severity level KNHNES KCHS
% Year % Year
3 Angina pectoris Mild 87.6 2005–2012 88.2 2008–2012
Moderate 3.1 2.1
Severe 9.3 9.7
5 Stroke Long-term consequences, mild 86.4 2005–2012 81.0 2008–2012
Long-term consequences, moderate 4.9 5.4
Long-term consequences, moderate plus cognition problems 6.5 6.0
Long-term consequences, severe 1.9 5.0
Long-term consequences, severe plus cognition problems 0.2 2.6
6 Asthma Controlled 53.9 2005–2012 52.4 2008–2012
Partially controlled 17.9 14.4
Uncontrolled 28.2 33.2
7 COPD & other respiratory problems Mild 66.5 2005–2012
Moderate 23.3
Severe 10.1
15 Major depressive disorder Mild 88.8 2007–2012 86.1 2009–2012
Moderate 9.8 10.8
Severe 1.5 3.1
20 Low back pain Acute without leg pain 97.7 2008
Acute with leg pain 0.2
Chronic without leg pain 0.3
Chronic with leg pain 1.7
22 Musculoskeletal problems: leg Mild 74.5 2005–2012 71.2 2008
Moderate 14.3 17.0
Severe 11.2 11.7
31 Anemia Mild 91.9 2005–2009 90.4 2008,2012
Moderate 6.1 6.9
Severe 2.1 2.7
32 Allergic rhinitis and conjunctivitis Mild 97.9 2005–2009 98.0 2008–2012
Moderate 2.1 2.0
KNHNES Korean National Health and Nutrition Examination Surveys, KCHS Korean Community Health Survey, COPD chronic obstructive pulmonary disease
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countries, it will be worth conducting similar studies in
situations that lack data on disease severity distributions.
There is a paucity of data on disease severity distribu-
tions, although data on prevalence are relatively access-
ible [7]. Even though data on severity distributions are
available, generalizability is limited in terms of the study
designs used to collect data [15–17] and evaluate disease
severity [18]. If there are national survey data on severity
distributions in a certain country [19], the applicability
of that data to other countries will be restricted due to
differences in race, socio-demographics, and healthcare
system accessibility. When collecting epidemiologic data,
including prevalence and incidence, data on severity dis-
tributions are also needed to fundamentally solve this
problem.
In our present study, we used 2 different population
survey data sets (KNHNES and KCHS) to estimate the
severity distributions. The estimated patterns for severity
distribution using KNHNES and KCHS were quite simi-
lar. For example, in the case of angina pectoris, the se-
verity distributions according to KNHNES were 87.6 %
(mild), 3.1 % (moderate), and 9.3 % (severe). The severity
distributions according to KCHS were 88.2 % (mild),
2.1 % (moderate), and 9.7 % (severe). These consistent
results between the 2 population surveys data indicate
that the reliability of this study is fair.
Overall, the proportion of participants with mild dis-
ease severity tended to be larger than moderate or severe
disease severity for each disease included in this study.
Because KNHNES and KCHS surveyed the general pub-
lic, there is a possibility that the proportions of moderate
or severe disease were underestimated. When compared
with the results of other epidemiologic studies, some
studies show similar results, whereas other studies dem-
onstrate divergent results. For example, Lee et al re-
ported that 51.8 % of their participants were stage 1 on
the BODE index (reflecting the systemic nature of
COPD), followed by 24.3 % at stage 2, 16.3 % at stage 3,
and 7.6 % at stage 4 [18]. In this study, we estimated the
severity distributions of COPD as follows: 66.5 % (mild),
23.3 % (moderate), and 10.1 % (severe). Furthermore,
Cho et al suggested that the majority of individuals with
low-back pain demonstrate low-intensity or disabling
pain [17]. In this study, we also estimated that the pro-
portion of cases with complicated, low-back pain was
small.
According to a multinational survey on asthma, how-
ever, only 27 % of patients from South Korea reported
having asthma that was well or completely controlled
[20]. In our present study, we predicted that 53.9 and
52.4 % of people with asthma were in control of their
disease according to KNHNES and KCHS data, respect-
ively. These results could be due to limitations in the
EQ-5D-3L used to evaluate asthma HRQoL. That is,
EQ-5D-3L might not reflect all aspects of asthma, so
further studies that use similar methods as this study, in-
cluding disease-specific HRQoL instruments, will be
needed to verify the reasons for the gap between reports.
This study has several limitations. First, we estimated
the EQ-5D-3L indices and cutoff points for 35 diseases
by severity, but the severity distributions were only de-
termined for 8 diseases due to limitations in the popula-
tion survey data. In KNHNES and KCHS, there are no
prevalence-based data for undetermined diseases such as
Parkinson’s diseases or sleep disturbance. However, if
prevalence-based data with HRQoL are generated, we
would be able to estimate the severity distributions of
other diseases using the cutoff points from our analyses.
Second, the survey participants were asked to complete
EQ-5D-3L for hypothetical persons in the order of good
health states. If our participants had completed the EQ-
5D-3L for hypothetical people in the order of bad health
states, different EQ-5D-3L indices might have been esti-
mated. Third, when applying the cut-off points from the
survey to the EQ-5D-3L indices of the KNHES and
KCHS, we could not consider comorbidity in the
KNHES and KCHS due to the limitation of data source.
A person with a certain disease may have other diseases
in the KNHES and KCHS, therefore, reported EQ-5D-3L
indices in a certain disease may be influenced by con-
comitant diseases. Comparing a person without any co-
morbidity in a certain disease, the reported EQ-5D-3L
indices in a certain disease would be underestimated and
the proportions of severe cases would be overestimated.
Conclusions
Using EQ-5D-3L, our present study has provided the se-
verity distributions of 8 diseases (asthma, angina, stroke,
COPD, major depressive disorder, musculoskeletal prob-
lem in legs, anemia, and allergic rhinitis and conjunctiv-
itis) in the Korean population. Using our approach, valid
disease burden could be calculated in the future in
South Korea and other countries using disease severity
distributions.
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